Psoriatic Arthritis News

The gap between patient-reported outcomes and clinician-assessed endpoints in rheumatology is well documented. Patients generally care about pain, fatigue and the emotional toll immune-mediated diseases can take, while physicians are more likely to pay attention to interleukin activity or C-reactive protein levels.

Etanercept monotherapy or a combination of etanercept and methotrexate had better psoriasis outcomes than methotrexate alone, according to a poster presented at the American Academy of Dermatology virtual meeting.

The FDA has issued a warning letter to MediNatura Inc., ordering the company to cease illegal marketing of unapproved injectable homeopathic products that claim to treat “inflammatory and degenerative conditions of the musculoskeletal system” and relieve pain, swelling and joint stiffness.

Lifestyle approaches, including physical activity and smoking cessation, should complement medical therapy in patients with rheumatic and musculoskeletal diseases, according to data presented at the EULAR 2020 E-Congress.

The availability of new drug options and new definitions for polyarticular versus oligoarticular joint involvement in psoriatic arthritis were highlighted as the significant updates in the EULAR recommendations for the treatment of the disease, according to a presenter at the EULAR 2020 E-Congress.

AbbVie has submitted applications to the FDA and European Medicines Agency for Rinvoq to include an indication for treatment of adult patients with active psoriatic arthritis, according to a press release.

Rheumatologists may consider “cautious tapering” of DMARDs in patients with psoriatic arthritis who achieve sustained remission, according to a 2019 update to EULAR recommendations published in Annals of the Rheumatic Diseases.

Losing weight from young adulthood into midlife is associated with a substantially reduced risk for arthritis, according to data published in Arthritis Care & Research.

The COVID-19 pandemic, in places like Detroit, with a large working-class population, can highlight the gap between the rich and the poor. It can demonstrate how political unrest can impact the response to a critical situation. Moreover, it can show how health care workers can face both personal and professional challenges in managing an outbreak of this magnitude.

Baseline use of biologics and JAK inhibitors among patients with immune-mediated inflammatory disease, such as rheumatoid arthritis, psoriatic arthritis, psoriasis and other related conditions, is not associated with worse COVID-19 outcomes, according to a case series presented in the New England Journal of Medicine.